HomeMost PopularThe Pursuit of Top Dividend Kings: Unveiling Promising Investment Avenues

The Pursuit of Top Dividend Kings: Unveiling Promising Investment Avenues

Actionable Trade Ideas

always free

The art of dividend growth investing stands as a beacon for those seeking long-term financial security. The allure of companies with robust dividend yields and promising growth trajectories is undeniable. Dividends not only offer consistent payouts but also provide investors with exposure to positive price movements over time.

Amid the realm of dividend investing lies a prestigious category of companies known as Dividend Kingsβ€”entities that have increased dividend payouts for over 50 consecutive years. This elite group holds fervent appeal for income-seeking investors.

The quest for high yields often blinds investors to other crucial factors. Ignoring these can pose risks in the long run.

While the Dividend King status reflects financial robustness and adept management, relying solely on past performance carries its own perils. The dynamism of the stock market mirrors that of the weatherβ€”it can swiftly change course without warning.

To shield against adverse market movements, supplementing the selection of Dividend Kings with additional indicators like Analyst Ratings proves to be judicious.

Decoding Analyst Ratings

Analyst Ratings amalgamate consensus estimates from various Wall Street and global analyst firms. This rating, often displayed on a 5-point scale, serves as a valuable yardstick for investors.

Incorporating Analyst Ratings into your stock selection process bolsters the often monochromatic view that single metrics, such as dividend yields, offer. Moreover, the psychological reassurance it offers adds a layer of confidence to investment decisions. After all, who doesn’t appreciate a stamp of validation from seasoned analysts?

Now, in the spirit of having your cake and eating it too, let’s delve into the domain of Dividend Kings offering not just high dividend yields but also boasting top-notch analyst ratings.

Coca-Cola Company (KO)

g6ilmsggr4uod9hcoghgkxuyqb8qfkdtwo 2mzmo21qhp5alzmklm tidmrprldeiettmf6g9pl5gwzyempmpxds osg0 dmnqtbob4ogcga0c46hsscucz0dn2ddzg cdjqovt6utbzuqp rpfzpbo

Alongside its global brand recognition, The Coca-Cola Company stands tall as a stalwart in the realm of reliable dividend stocks. Boasting the coveted titles of Dividend Aristocrat, Dividend King, and even Dividend Zombie, this company has garnered a rare distinction.

Encompassing production, marketing, and distribution of its iconic sodas across the globe, KO maintains an extensive network of bottling and distribution partners worldwide.

The past year proved fruitful for Coca-Cola, with net revenue for 2023 witnessing a 6% growth. Notably, its organic revenue surged robustly across all segments. Moreover, the company exhibited a 13% growth in earnings per share (EPS), culminating at $2.47, comfortably surpassing its dividend rate.

Having a track record of 104 years of dividend payments and 62 consecutive years of dividend increases, Coca-Cola presently offers a $1.94 forward dividend, translating to a 3.22% yield at the March 19th closing price. Analysts have bestowed a Strong Buy rating of 4.47 out of 5 upon Coca-Cola.

Abbvie Inc (ABBV)

rv8 17t4n0g si08bddvdxujsyb1jmj7xjtkr4e2ar0xomp1nyopbg496dwwr0uym7izyz8pd3y pxrfdoq

Abbvie Inc., a distinguished Dividend King and Aristocrat, stands as a prominent US-based pharmaceutical company, commanding a notable position in the global biomedical landscape. Focusing on immunology, oncology, neuroscience, eye care, and aesthetics, the company boasts an extensive array of over 90 drugs and medical devices in its pipeline.

Prized for its emphasis on research and development, ABBV allocates over $7.1 billion towards enhancing its product portfolio and services. Serving a diverse clientele, ranging from wholesalers and distributors to direct healthcare facilities and governmental bodies, Abbvie Inc. epitomizes innovation and excellence in the pharmaceutical domain.

The company offers a forward annual dividend rate of $6.20, boasting a 3.45% yield based on prevailing prices. With a dividend payment streak spanning 52 years, Abbvie Inc. enjoys a Moderate Buy consensus rating of 4.16 out of 5 among 19 analyst firms, with 10 specifically prescribing a Strong Buy rating.

Federal Realty Investment Trust (FRT)

v1ns0diu 2evu0dcj3tgyrvnu3aern2imahnk3rucmyxygovmrjvyhp6m1wjgore6ruuxgbrxzlan6rwwx4qa3jqa af7rdgbep7rm7jdbrgtqsa9uqdg6lzbimn3 sc4dehlromzj8t fznfue13k0

Federal Realty Investment Trust stands as a venerable REIT, etching its place as one of the oldest in the United States. This longstanding presence attests to the company’s enduring expertise and stability in the real estate investment landscape.






Fortune REIT: The Jewel of Real Estate Investment Trusts

Fortune REIT: The Jewel of Real Estate Investment Trusts

Fortune Real Estate Investment Trust (FRT) shines bright in the realm of real estate investing, focusing its resources on high-quality retail properties ranging from grocery-anchored shopping centers to vast mixed-use neighborhoods.

Reveling in the current market climate, FRT remains a stalwart contender as it revels in consistent earnings. As a Real Estate Investment Trust (REIT), FRT adheres to legal regulations mandating the distribution of a significant portion of its earnings as dividends. Consequently, FRT emerges as a prime contender for dividend-seeking investors.

In a resplendent forecast, FRT anticipates its Funds From Operations (FFO) per diluted share to ascend within the range of $6.65 to $6.87 by 2024, a notable elevation from $6.55 in 2023. This robust growth projection underscores the company’s ability to cover its dividend disbursements with poise and efficiency, making it a beacon of stability in tumultuous financial waters.

At present, FRT offers investors a tantalizing dividend rate of $4.36 per share, translating to a handsome 4.37% yield at prevailing market prices. Impressively, FRT has cultivated a distinguished legacy of dividend increments, boasting a track record of elevating dividends for 56 consecutive years. This enviable performance has not gone unnoticed, evident in the company’s stellar Moderate Buy rating of 4.12, bestowed by 17 esteemed analysts. Such recognition cements FRT’s standing as a premium choice for those seeking both dividend income and pronounced capital growth.

Parting Words of Wisdom

Allow me to reiterate a timeless adage: in the realm of stock evaluation, wisdom dictates a holistic approach. Whether one extols FRT as a Dividend King or not, prudent investors should transcend singular metrics. Barchart, a venerable ally in the financial realm, bestows upon you an array of tools to illuminate your path to investment enlightenment. It behooves you to avail yourself of these resources and navigate the financial landscape with sagacity.

For more insightful stock market updates, visit Barchart

On the publication date, Rick Orford did not hold any positions, either directly or indirectly, in the securities mentioned in this article. All information and data provided in this article are strictly for informational purposes. For further details, kindly refer to the Barchart Disclosure Policy.

The eloquent views expressed here are the author’s own and do not necessarily align with those of Nasdaq, Inc.

Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.